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Abstract 
Background: With the continued integration of engineered nanomaterials (ENMs) into everyday applications, it is impor‑
tant to understand their potential for inducing adverse human health effects. However, standard in vitro hazard characteri‑
sation approaches suffer limitations for evaluating ENM and so it is imperative to determine these potential hazards under 
more physiologically relevant and realistic exposure scenarios in target organ systems, to minimise the necessity for in vivo 
testing. The aim of this study was to determine if acute (24 h) and prolonged (120 h) exposures to five ENMs  (TiO2, ZnO, Ag, 
 BaSO4 and  CeO2) would have a significantly different toxicological outcome (cytotoxicity, (pro‑)inflammatory and genotoxic 
response) upon 3D human HepG2 liver spheroids. In addition, this study evaluated whether a more realistic, prolonged frac‑
tionated and repeated ENM dosing regime induces a significantly different toxicity outcome in liver spheroids as compared 
to a single, bolus prolonged exposure.
Results: Whilst it was found that the five ENMs did not impede liver functionality (e.g. albumin and urea production), 
induce cytotoxicity or an IL‑8 (pro‑)inflammatory response, all were found to cause significant genotoxicity following acute 
exposure. Most statistically significant genotoxic responses were not dose‑dependent, with the exception of  TiO2. Interest‑
ingly, the DNA damage effects observed following acute exposures, were not mirrored in the prolonged exposures, where 
only 0.2–5.0 µg/mL of ZnO ENMs were found to elicit significant (p ≤ 0.05) genotoxicity. When fractionated, repeated expo‑
sure regimes were performed with the test ENMs, no significant (p ≥ 0.05) difference was observed when compared to the 
single, bolus exposure regime. There was < 5.0% cytotoxicity observed across all exposures, and the mean difference in IL‑8 
cytokine release and genotoxicity between exposure regimes was 3.425 pg/mL and 0.181%, respectively.
Conclusion: In conclusion, whilst there was no difference between a single, bolus or fractionated, repeated ENM pro‑
longed exposure regimes upon the toxicological output of 3D HepG2 liver spheroids, there was a difference between acute 
and prolonged exposures. This study highlights the importance of evaluating more realistic ENM exposures, thereby provid‑
ing a future in vitro approach to better support ENM hazard assessment in a routine and easily accessible manner.
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Background
Nanotechnology is considered an important Key Ena-
bling Technology (KET), underpinning a variety of novel 
applications across wide ranging sectors. As a global 
market, nanotechnology reached $75.8 billion in 2020 
and is predicted to exceed $125 billion in the next three 
years, with engineered nanomaterials (ENMs) defined 
as having the greatest share of the global nanotechnol-
ogy market [1]. ENMs are manufactured materials with 
advanced size specific physico-chemical properties 
derived from an unbound, monodispersed state, or as an 
aggregate/agglomerate where 50% or more of the parti-
cles possess one or more external dimensions in the size 
range 1–100 nm [2]. This greater surface area to volume 
ratio enables ENMs to harbour advantageous properties 
that improve the functionality of a plethora of applica-
tions (e.g. cosmetics, medicine, electronics, construction 
and energy industries) providing great opportunities for 
economic growth and life improving technologies. Con-
sequently, with increasing human and environmental 
exposure comes the need to understand any potential 
associated safety risks.
Human ENM exposure occurs via four primary routes; 
inhalation, ingestion, injection and dermal penetration. 
With the exception of certain medical treatments, the 
prospect of injecting ENMs into the body is relatively 
low for the majority of individuals. While for most ENM, 
the likelihood of occupational inhalation exposure is pre-
dominant, such as the use of barium sulfate  (BaSO4) and 
cerium dioxide  (CeO2) in the automotive industry; other 
routes of potential relevant exposure could arise from the 
use of consumer products, with some examples being the 
ingestion of food grade titanium dioxide  (TiO2) or dermal 
penetration of sunscreen enhancing zinc oxide (ZnO) 
[3–6]. Silver (Ag) ENMs, with its popular anti-microbial 
properties, are deemed the most readily applied ENM in 
consumer products included in the top three applications 
found in medicine, textiles and cosmetic products [7–9]. 
Consequently, understanding the impact of repeated 
ENM exposure to human health over prolonged periods 
of time is imperative.
Once ENMs have entered the body, if they have the 
ability to traverse biological barriers and enter circula-
tion, the materials can translocate to secondary sites of 
deposition, including the spleen, liver and kidneys [10, 
11]. Of these sites, the liver is of particular toxicological 
importance due to its high susceptibility to ENM depo-
sition and accumulation, as well as its role in maintain-
ing metabolic homeostasis and the detoxification of 
both endogenous and exogenous substances [12, 13]. 
Secondary ENM deposition in the liver is commonly 
reported, but it is becoming more evident that translo-
cation following inhalation or ingestion in particular, is 
low with < 1.0% of the insoluble ENM exposure concen-
tration reaching the secondary organs [14]. A previous 
in vivo study undertaken to assess the effects of an occu-
pational 14-day pulmonary exposure, found that only 
1.24% and 2.87% of the original intratracheal instilled 
dose of 162  µg of  TiO2 and  CeO2 ENMs per mouse 
reached the liver [15]. This corresponds to a translo-
cated dose of 1  µg/g in  vivo or 1  µg/mL in  vitro [15], 
illustrating the necessity for low-dose exposures when 
evaluating the effect of ENM exposure upon secondary 
sites of exposure, such as the liver. Even at low-doses, 
ENMs have been found to induce hepatic dysfunction 
and severe organ damage in  vivo. Liver damage caused 
by the long-term (90  days), daily intragastric exposure 
of 2.5–10 µg/g of  TiO2 resulted in bioaccumulation and 
aggregation in the liver over time, significant changes in 
tissue morphology and the expression of genes involved 
in immune and inflammatory responses (e.g. CXCII 
over-expression), apoptosis, oxidative stress and meta-
bolic process [16]. Similarly, low dose (< 10.0  µg/mL) 
in vitro ENM exposures of Ag and ZnO were sufficient 
to induce biological effects, including DNA damage 
and elevated levels of reactive oxygen species (ROS). 
Yet, many in  vitro studies have previously focused on 
the acute effects of high ENM concentrations, which is 
beneficial for establishing potential toxicity and hazard, 
but does not allow for evaluation of the chronic effects 
that may be associated with the more realistic long-term 
human exposure scenarios [14, 17]. Prolonged expo-
sure to ENMs may induce repetitive injury leading to 
chronic liver disease, whereby the regenerative capabili-
ties are impaired, and the hepatocytes begin to undergo 
cell death as a result of inflammation [12, 18]. Therefore, 
continued ENM exposure raises concerns regarding the 
gradual accumulation and chronic health effects that 
may be induced.
With the vast range of ENMs available on the mar-
ket, each with its own unique specification, it is unten-
able to rely on in vivo based methods to fully elucidate 
the immediate and lasting effects of ENM exposure 
upon the human body [19]. In recent years, interna-
tional bodies such as the Organisation for Economic 
Cooperation and Development (OECD) Working Party 
on Manufactured Nanomaterials, the International 
Organization for Standardization (ISO) and the Euro-
pean Committee for Standardization (CEN) have pub-
lished a series of test guidelines, guidance documents 
and regulatory standards to help drive the development 
of physiologically relevant, high-throughput in  vitro 
test systems and regulated protocols for ENM hazard 
assessment [20]. To align with these new test guidelines 
and the 3Rs directive to replace, reduce and refine the 
use of in  vivo based testing systems, researchers have 
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been developing advanced in  vitro models to emulate 
human organ systems and sustain long-term culture, to 
provide viable alternatives to in  vivo test systems and 
to propel in  vitro ENM hazard assessment screening 
forward.
The development of 3D liver models has been an 
important advancement as they have been shown to bet-
ter encapsulate organ morphology and intricate multi-
cellular interactions, while demonstrating improved 
hepatic function, metabolic activity, and extended cul-
ture longevity [12, 21–24]. To date, the longest viable 
hepatic model in  vitro is described to be functional for 
up to 5  months with the use of an inverted colloidal 
crystal extracellular matrix (ECM) to aid the formation 
of hepatic hexagonal architecture with primary human 
foetal hepatocytes [25]. Though this model has the capa-
bility to parallel in vivo based long-term exposure stud-
ies, the use of an ECM scaffold, however, poses different 
challenges for ENM hazard assessment [26, 27]. Some 
3D hepatic in  vitro models based on primary human 
hepatocytes (PHH) can remain viable for up to 21 days in 
culture; whilst they can be utilised for the evaluation of 
e.g. viability, hepatic functionality, metabolic activity and 
pro-inflammatory response, they do not actively prolifer-
ate and so cannot be used for genotoxicity testing which 
often requires proliferating cells [14]. To overcome this, 
a proliferating cell-line based 3D in  vitro HepG2 sphe-
roid model has been developed, which can be utilised to 
evaluate multiple toxicological endpoints including gen-
otoxicity [28, 29]. HepG2 cells have shown phenotypic 
secretion of hepatic plasma proteins (e.g. albumin, fibrin-
ogen and transferrin), phase II gene expression and the 
capability to positively identify pro-carcinogens and six 
out of nine drug-induced liver injury (DILI) compounds 
[24, 30, 31].
Given the limitations associated with standard in vitro 
hazard testing approaches, this study aimed to determine 
if more realistic prolonged and repeated ENM exposure 
regimes exhibited different (geno)toxicological outcomes 
as compared to standard acute exposures when utilising 
3D liver spheroids. Five ENMs were selected based on 
the ECETOC DF4nanoGrouping decision-making frame-
work for the grouping and testing of ENM, to provide a 
range of materials that possess different physico-chemical 
characteristics and exhibit varying dissolution and trans-
formation capacities in a biological environment;  TiO2 
and  CeO2 defined as active, insoluble materials, ZnO and 
Ag defined as soluble, ionic materials and  BaSO4 defined 
as a passive, non-reactive material [32, 33]. Furthermore, 
this study sought to determine the genotoxic potency of 
these materials, at physiologically relevant, low exposure 
concentrations of 0.2–10.0 µg/mL, upon the 3D in vitro 
liver models.
Results
ENM intrinsic and extrinsic physico‑chemical 
characterisation
Deemed as the defining features responsible for the ben-
eficial integration of ENMs into various applications and 
the drivers of ENM toxicity, the characterisation of indi-
vidual ENM physico-chemical properties is crucial in 
understanding the interaction, uptake, translocation and 
potential adverse effects of these materials within biolog-
ical systems. Five different metallic ENMs were evaluated 
using physico-chemical characterisation techniques to 
assess ENM composition, crystallinity, size, surface area, 
surface properties (e.g. coating, charge, reactivity), solu-
bility, dissolution and bio-persistence.
A summary of all the intrinsic and extrinsic physico-
chemical characteristics of the test ENMs are provided in 
Table  1. The five materials, whilst composed of varying 
metals, share a similar size and density of 10–50 nm in 
diameter and 3.5–8.5 g/cm3, respectively. All the ENMs 
exhibit a similar primary particle size, but they have dif-
ferent specific surface areas (as measured by BET) with 
Ag possessing the lowest specific surface area of 6.4  m2/g 
and  TiO2 possessing the highest specific surface area of 
51.0  m2/g. All the ENMs have a negative surface charge 
at pH 7 in 10 mM of KCl water solution, with the excep-
tion of  CeO2 with a positive surface charge of +35.2 
mV. Only two ENMs, Ag and ZnO, both of which are 
commonly found to dissociate into ions, have a surface 
coating; functionalized PVP and UV activated silicon, 
respectively. Further to this, according to the definitions 
set out by Arts et al., they are the only two ENMs tested 
in this study that are hydrophobic, with a water contact 
angle >90°. Yet, they were both originally categorized as 
‘soluble, non-persistent ENMs’ by the ECETOC DF4na-
noGrouping decision-making framework, pertaining to 
the high rates of dissolution observed [32, 33].
The colloidal behaviour of the five ENMs in the test 
medium (DMEM) over a period of 24 and 120  h was 
determined using dynamic light scattering (DLS), as 
shown in Table  2. In conjunction, the polydispersity 
index (PDI; measure of ENM sample heterogeneity 
based on size), and zeta potential (ZP; surface charge), 
of the materials was measured. For  TiO2, we observed 
a concentration dependent increase in size distribu-
tion, from ~20 nm (0.2 µg/mL) to 300 nm (10 µg/mL). 
We found comparable results in the size distribution 
after 24 and 120 h exposure that confirms the ability of 
complete DMEM medium to preserve colloidal stabil-
ity of  TiO2 ENMs, even after prolonged exposure. How-
ever, all the samples showed high PDI values, presenting 
polydispersion in the size distribution (3 main popula-
tions were detected at all concentrations). The ZP data 
was set around −10 mV which aligns the with ZP value 
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of complete DMEM and confirms the presence of a uni-
form protein corona surrounding the ENMs at all expo-
sure concentrations and time points. The only difference 
detected with ZnO ENMs in complete DMEM, in com-
parison with  TiO2, is that the size remained below 50 
nm for all the samples tested and thus do not exhibit a 
tendency to actively agglomerate. As for  TiO2, the ZnO 
ZP values do not significantly change as a function of 
time and exposure concentration, remaining within 0 to 
−10 mV, illustrating little surface charge to encourage 
agglomeration. In Ag samples, after 24 h, the samples 
showed a broad distribution, with an abrupt increase in 
diameter for more concentrated samples (2.0–10.0 µg/
mL). However, after 120  h, the particle size distribu-
tion was narrower and the mean size values are reduced 
(1.0–10.0 µg/mL samples). Also, in this case, the most 
reliable hypothesis is that the larger diameter particles 
sedimented and the complete DMEM stabilized the 
nano-fraction left in suspension.  BaSO4 ENMs appear 
very small and exhibit a narrow size distribution for all 
the samples, resulting in a standard deviation around a 
few nanometers. The ENM agglomerate size almost dou-
bles from 0.2 to 10.0 µg/mL at both time points, but this 
material demonstrated the greatest stability and disper-
sion. In a similarly manner to  TiO2,  CeO2 ENMs dis-
played an increase in size distribution correlated with an 
increase in the exposure concentration. However, follow-
ing 120 h exposure, the difference in size data between 
the lower and higher concentrations were very low. In 
fact, even if there is a 2-fold increase in  CeO2 concen-
tration, the mean diameter only slightly increases in size 
and retains a narrow distribution. Whilst this behaviour 
is indicative of an increase in colloidal stability versus 
time, it is more likely due to a partial sedimentation of 
larger particles that reduce particle size distribution over 
time.
Dissolution studies in the cell incubation media 
showed similar trends as the biological clearance data 
summarized by Arts et  al., but there are apparent disa-
greements with the REACH grouping categories [32]. 
ZnO showed high 24 h solubility (~10.0 µg/mL) followed 
by  BaSO4 (2.4 µg/mL) and Ag (0.01 µg/mL), while disso-
lution of  TiO2 and  CeO2 was not observed (Table 1) [32]. 
This information suggests that the applied realistic doses 
for ZnO are borderline to the 24 h solubility level in the 
test media. As a result, the associated detrimental effects 
to the HepG2 cells in the experiments with ZnO may, to 
a great extent, be induced by the dissolved  Zn2+ ions and 
not the ENM. With regards to  CeO2, it was observed that 
2.4 µg/mL was dissolved after 24 h. Consequently, parti-
cle-induced effects were not expected until the second-
highest dose applied in this study, unless the effects are 
very acute.
Analysis of the particle pH and oxygen  (O2) reactivi-
ties (Fig. 1) in the test medium showed minor effect with 
an increase in pH (~0.2–0.3 pH units) for ZnO. This is 
a lower pH effect than reported in Da Silva et al., where 
pH increased to above pH 9 in Hams F12 + 10% FBS 
+ 1% Pen/Strep [36, 37]. Changes in the pH of the test 
medium are driven by the dissolution of the ENMs into 
different ions. For example, the observed pH increase for 
ZnO, which mainly occurred within the first 15 mins of 
the test, is explained by the dissolution of ZnO into  Zn2+ 
ions and two hydroxide ions. Similar fast kinetics was 
observed by the pH increase in this study too. In con-
trast to ZnO, all the other 4 materials resulted in a pH 
decrease. For  BaSO4, the decrease was minor, while it 
was pronounced and persistent for Ag (~ −0.2 pH units).
The temporal oxidative  (dO2) reactivity is understood 
directly as the extent by which the test material, as a 
result of redox reactivities and potential dissolution, 
causes changes in the  O2 concentration dissolved in the 
test medium with and without the presence of the ENM. 
With regards to the oxidative behaviour (Fig. 1B),  BaSO4, 
Ag, and  TiO2 showed a moderate increase in  O2 within 
the first 500–700 mins after which the oxidative reac-
tion is neutralised. On a relative scale between the 5 test 
materials,  TiO2 followed by  BaSO4 appear to be the mate-
rials with the highest initial  dO2 reactivity. The relatively 
short duration of the observed reactivity suggests that the 
potential biological effect of material-induced changes 
in  dO2 will be due to reactions within the first 200–600 
mins after exposure is initiated.
Single bolus, acute and prolonged ENM exposures
Acute, single bolus ENM exposures are commonly used 
for in  vitro ENM hazard assessment and were under-
taken to establish a foundation for which to compare pro-
longed and repeated ENM exposure regimes against.
Liver functionality: albumin and urea
To establish that no significant loss to liver functional-
ity in the 3D HepG2 models occurred and that their 
fidelity was maintained following either acute (24 h) or 
prolonged (120  h) ENM exposures, the levels of both 
albumin and urea were assessed.
Albumin levels were found to remain relatively sta-
ble across the dose-range for each test ENM evaluated 
(Table  3). The concentration of albumin was generally 
greater following longer-term culture than acute expo-
sure periods, which is to be expected as albumin accu-
mulates with increasing culture time of the 3D spheroids 
[29]. There was no significant change in albumin lev-
els following longer-term exposure to any of the ENMs 
tested, nor with acute exposure to  TiO2, ZnO or  CeO2. 
However, a significant (p ≤ 0.05) reduction in albumin 
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Table 2 The colloidal behaviour of  TiO2, ZnO, Ag,  BaSO4 and  CeO2 ENMs once exposed to DMEM complete media for 24 and 120 h.




pH Size DLS (nm) PDI Zeta Pot. (mV)
Mean Stdev Mean Stdev
TiO2
NM 105
0.2 24 7.6 23 1 0.6 − 8.8 0.6
0.5 24 7.7 108 64 0.3 − 10.2 0.6
1 24 7.6 112 49 0.4 − 9.9 0.4
2 24 7.7 226 46 0.3 − 8.0 0.4
5 24 7.7 216 24 0.7 − 10.3 0.8
10 24 7.6 282 22 0.6 − 9.8 0.6
0.2 120 7.8 37 2 0.6 − 5.9 0.5
0.5 120 7.8 97 21 0.3 − 10.0 0.8
1 120 7.9 71 2 1.0 − 10.2 0.3
2 120 7.9 232 24 0.5 − 13.1 0.9
5 120 8.4 152 10 0.5 − 12.6 1.1
10 120 8.0 275 10 0.4 − 10.1 0.7
ZnO
NM 111
0.2 24 7.6 21 3 0.4 − 7.8 0.9
0.5 24 7.7 25 3 0.6 − 6.7 1.6
1 24 7.7 22 4 0.4 − 4.3 0.8
2 24 7.7 20 1 0.4 − 7.7 0.5
5 24 7.7 50 12 0.4 − 4.4 0.9
10 24 7.7 74 43 0.2 − 8.3 0.8
0.2 120 7.8 30 1 0.5 − 7.5 0.8
0.5 120 7.8 28 1 0.8 − 5.8 1.2
1 120 7.8 28 4 0.6 − 6.9 0.6
2 120 7.8 40 3 0.6 − 6.8 1.8
5 120 7.8 63 6 0.6 − 5.1 0.9
10 120 7.9 36 1 0.5 − 9.2 0.5
Ag
Sigma 576832
0.2 24 7.8 26 1 0.7 − 7.9 1.3
0.5 24 7.8 43 13 0.4 − 9.5 0.7
1 24 7.8 138 11 0.2 − 10.9 1.6
2 24 7.8 244 166 0.3 − 10.0 0.8
5 24 7.8 273 186 0.4 − 10.4 1.3
10 24 7.8 308 36 0.3 − 11.3 0.8
0.2 120 8.1 79 2 0.4 − 11.1 1.6
0.5 120 8.0 73 2 0.4 − 11.2 0.3
1 120 7.9 117 3 0.6 − 7.7 0.8
2 120 8.1 89 3 0.4 − 10.8 0.9
5 120 7.9 109 16 0.4 − 9.3 0.8
10 120 7.9 150 16 0.3 − 7.5 0.7
BaSO4
NM 220
0.2 24 7.6 20 1 0.4 − 8.6 0.5
0.5 24 7.6 27 2 0.7 − 9.5 0.8
1 24 7.6 21 1 0.5 − 8.1 0.9
2 24 7.6 21 1 0.6 − 9.6 0.9
5 24 7.7 32 1 0.8 − 9.6 0.2
10 24 7.7 41 3 1.0 − 11.6 0.8
0.2 120 7.8 51 1 0.6 − 4.1 0.9
0.5 120 7.8 54 2 0.6 − 7.7 0.4
1 120 7.8 59 1 0.6 − 8.1 0.7
2 120 7.8 66 2 0.6 − 4.6 1.3
5 120 7.8 80 1 0.6 − 8.3 1.0
10 120 7.8 95 1 0.6 − 10.0 0.8
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was observed following 24 h exposure to the higher doses 
(5.0 µg/mL and 10.0µg/mL) of Ag and  BaSO4 ENMs.
In a similar manner to albumin, the concentration of 
urea produced by the HepG2 spheroids also remained 
consistent across all ENM exposures (Table 4). A signif-
icant reduction (p = 0.0061) in urea was only observed 
following acute exposure to 10.0 µg/mL of ZnO and 
longer-term exposure to 5.0 µg/mL of  TiO2.
(Pro)‑inflammatory response: IL‑8, IL‑6 and TNF‑α cytokine 
release
Following ENM exposure, IL-6, IL-8 and TNF-α cytokine 
levels were assessed to investigate the induction of any 
potential (pro-)inflammatory response. Attributable 
to the 3D liver spheroid model being a monoculture of 
HepG2 epithelial-like cells, all IL-6 and TNF-a results 
were found to be below detectable limits regardless of 
ENM tested or exposure-regime applied and so these 
cytokines were not considered further (data not shown). 
In contrast, IL-8, an acute phase chemokine released by 
hepatic epithelial cells, was modified in response to the 
ENM exposures as illustrated in Fig. 2. When comparing 
the IL-8 response between acute and prolonged expo-
sure regimes for  TiO2, ZnO,  BaSO4 and  CeO2, there was 
an increase in the concentration of IL-8 present across 
the dose range. Exposure to 0.5 µg/mL of  TiO2 induced 
the only significant (p = 0.0042) increase in IL-8 follow-
ing acute exposure, which was no longer observed after 
120  h (Fig.  1A). Instead, as the concentration of  TiO2 
increased in the longer-term exposure, the concentration 
of IL-8 present decreased with 5.0 µg/mL and 10.0 µg/mL 
 TiO2 inducing a significant (p ≤ 0.01) reduction in IL-8. 
Neither ZnO (Fig. 2B), or Ag (Fig. 2C) induced any signif-
icant changes in IL-8 production following either acute 
or prolonged low-dose ENM exposure with both show-
ing a similar trend to the control across the dose range. 
Fig.  2D demonstrates that  BaSO4 was the only material 
to induce an increase in IL-8 across the 2.0–10.0 µg/mL 
dose range. However, significance (p = 0.0261) was only 
achieved at the single dose of 0.2 µg/mL  BaSO4. Expo-
sure to  CeO2, Fig. 2E, resulted in IL-8 induction at 0.2 µg/
mL and 0.5 µg/mL following acute exposures and across 
the prolonged exposure dose range (0.2 and 2.0 µg/mL). 
However, none of these IL-8 peaks were found to be sig-
nificant despite being up to 3-fold higher than the nega-
tive control.
Cytotoxicity and genotoxicity
To determine if the test materials induced fixed DNA 
damage following both acute and prolonged exposure, 
the micronucleus (MN) assay was employed in conjunc-
tion with an appropriate cytotoxicity assay.
As shown in Fig. 3, cytotoxicity was not induced fol-
lowing either acute or prolonged exposure to any of the 
test ENM up to a top dose of 10.0 µg/mL of material. 
In contrast, a significant dose-dependent increase in 
genotoxicity was observed with all test ENMs following 
acute exposure. With  TiO2, the lowest observed adverse 
effect level (LOAEL) was 2.0 µg/mL (p = 0.0052); the 
frequency of MN induction increased further at 5.0 
µg/mL (p < 0.0001), where the MN frequency was 2.4-
fold higher than the negative control. Similar to  TiO2, 
Table 2 (continued)




pH Size DLS (nm) PDI Zeta Pot. (mV)
Mean Stdev Mean Stdev
CeO2
NM 212
0.2 24 7.6 21 2 0.5 − 6.5 0.4
0.5 24 7.6 24 1 0.7 − 7.4 0.8
1 24 7.7 109 53 0.4 − 6.6 0.2
2 24 7.7 351 218 0.4 − 10.2 0.6
5 24 7.7 598 446 0.8 − 8.1 0.9
10 24 7.7 392 116 0.5 − 10.7 1.0
0.2 120 8.2 76 1 0.4 − 7.0 1.3
0.5 120 7.9 56 3 0.6 − 7.3 0.4
1 120 7.8 98 4 0.8 − 4.5 0.5
2 120 7.8 90 42 0.7 − 6.7 0.3
5 120 7.9 114 1 0.6 − 9.4 0.7
10 120 7.9 194 29 0.4 − 9.1 0.6
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Fig. 1 Surface plot shows the 24 h (1400 min) temporal pH reactivity (dpH) (A) and temporal oxidative reactivity (dOx) (B) for  CeO2 (NM‑212), 
 BaSO4 (NM‑220), ZnO (NM‑111), Ag (Sigma 576832) and  TiO2 (NM‑105) in DMEM + 10% FBS + 1% Pen/Strep cell culture medium, during in vitro test 
conditions using the SDR method
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whilst Ag,  BaSO4 and  CeO2 did not induce a significant 
increase in genotoxicity following prolonged exposures, 
each material was shown to induce a significant acute 
genotoxic response. Ag (Fig.  3C) displayed a signifi-
cant increase in genotoxicity following 24 h exposure to 
0.5 µg/mL (p = 0.0033), 1.0 µg/mL (p=0.0004) and 5.0 
µg/mL (p = 0.0032); although the observed effect was 
a plateau with all doses exhibiting an MN frequency 
2.05–2.51%.  BaSO4 induced a significant genotoxic 
response with all but one concentration, 1.0 µg/mL, 
following acute exposure as illustrated in Fig. 3D. Simi-
larly to Ag, acute exposure to  CeO2 (Fig.  3E) induced 
a significant genotoxicity response at 3 concentrations: 
0.5 µg/mL (p = 0.0185), 5.0 µg/mL (p =  0.0191) and 
10.0 µg/mL (p = 0.0209). ZnO (Fig.  3B) was the only 
material to exhibit both an acute and prolonged effect 
upon genotoxicity in 3D HepG2 liver spheroids. ZnO 
appears to induce different patterns of genotoxicity 
between the acute and prolonged exposure regimes. 
The acute genotoxic response appears to peak and 
trough, whereby ZnO induces a significant increase in 
genotoxicity at 0.5 µg/mL (p < 0.0001), 1.0 µg/mL (p = 
0.0083), 5.0 µg/mL (p < 0.0001) and 10.0 µg/mL (p = 
0.0001). In contrast, following the prolonged exposure, 
genotoxicity increased in a dose dependent manner 
up to 1.0 µg/mL and then plateaued, with the top dose 
reducing back to control levels. As shown by Fig.  3, 
none of the other test materials induced a significant 
positive induction of genotoxicity following prolonged 
exposure. Considering the acute (24 h) data, the gen-
otoxicity potency ranking based on the dose response 
relationship and the greatest fold-change in MN induc-
tion is: ZnO >  TiO2 >  BaSO4 =  CeO2 > Ag.
Fractionated repeated, prolonged ENM exposures
Fractionated, repeated prolonged ENM exposures were 
also investigated to more accurately simulate human 
ENM exposure and to determine if the added complexity 
of the exposure regime would significantly affect the toxi-
cological outcome in 3D HepG2 liver spheroids. Whilst 
both exposure regimes resulted in the same final expo-
sure concentration, the manner in which the ENMs were 
exposed to the spheroids differed between a single, bolus 
dose on day one and a repeated, fractionated dose given 
every day for the entire five day exposure, as illustrated in 
Fig. 4.
Liver functionality: albumin and urea
To ensure the HepG2 spheroids maintained their phe-
notypic functionality following both ENM prolonged 
exposure regimes, the levels of both albumin and urea 
were measured post exposure. For both albumin and 
urea concentrations, there was no significant difference 
between prolonged single, bolus, and repeated, frac-
tionated exposure regimes irrespective of the test ENM 
applied or the dose. Based on the values in Table 5, the 
average range between the mean albumin and urea val-
ues for each exposure regime was 3.84 ng/µL of albu-
min and 0.06 ng/µL of urea. Thus, the manner in which 
the 3D HepG2 liver spheroids are exposed to ENM over 
prolonged exposure regimes was not observed to signifi-
cantly impede liver functionality.
(Pro)‑inflammatory response: IL‑8, IL‑6 and TNF‑α cytokine 
release
With the complex interplay of inflammatory media-
tors, feedback loops and pathway cascades, timing is 
crucial with inducing a (pro-)inflammatory response. 
Therefore, it was important to establish if modifying 
the prolonged exposure regime to a repeated, fraction-
ated exposure method as opposed to a single, bolus 
exposure on day one, would affect the (pro-)inflamma-
tory response in HepG2 spheroids. In a similar manner 
to the acute and prolonged exposure studies described 
earlier, IL-6, IL-8 and TNF-α cytokine release was 
assessed for both the prolonged single, bolus and the 
repeated, fractionated ENM exposure regimes, but 
only an IL-8 (pro-)inflammatory release was detectable 
(Fig. 5). Prolonged exposure to both 0.5 µg/mL and 5.0 
µg/mL of  TiO2 and ZnO ENMs dosed via the two dif-
ferent methods, showed no significant difference in the 
IL-8 (pro-)inflammatory response in the HepG2 liver 
spheroids. For the individual test ENMs, there appears 
to be little to no difference at all in the concentration of 
IL-8 released following exposure to either material.
Cytotoxicity and genotoxicity
To mimic a gradual accumulation of ENMs and deter-
mine the effect this may have on DNA damage and 
cytotoxicity in HepG2 liver spheroids, spheroids were 
dosed with  TiO2 and ZnO ENMs via two techniques; 
a single, bolus dose or a repeated, fractionated dose. 
Exposing 3D HepG2 liver spheroids to either  TiO2 or 
ZnO, irrespective of dose, did not induce a significant 
increase in cell death or MN frequency as compared to 
the untreated control (Fig.  6). Furthermore, there was 
no significant difference in the cytotoxicity or genotox-
icity observed when comparing the single, bolus dose 
on day one versus the repeated, fractionated dose every 
day in 3D HepG2 liver spheroids.
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Discussion
It is widely acknowledged that it is unsustainable and 
ethically divisive to rely primarily on in  vivo based 
test systems for comprehensive ENM hazard assess-
ment, as such, research into suitable, physiologically 
relevant in  vitro alternatives has been at the forefront 
of nanotoxicology in recent years. Not only have sci-
entists strived to alleviate the limitations of current 
in  vitro models to enhance the longevity and predic-
tivity of the models, but, as in the present study, there 
have been recent efforts to start addressing the man-
ner in which humans are exposed to ENMs in natural 
life [38, 39]. This study aimed to determine, firstly, if 
a more realistic, low-dose prolonged ENM exposure 
would provoke a significantly different (geno)toxicolog-
ical effect compared to an acute exposure in 3D HepG2 
spheroids. Secondly, this study aimed to determine if 
a daily repeated, fractionated ENM exposure regime 
would significantly alter the toxicological outcome in 
3D HepG2 spheroids compared to a single, bolus pro-
longed exposure. To assess this, a cell-line based 3D 
in  vitro HepG2 spheroid model able to evaluate cyto-
toxicity, (pro-)inflammatory response and genotoxicity 
associated with both acute and longer-term (≤ 10 days) 
ENM exposure upon the liver was utilised. In this sys-
tem, hepatocyte spheroids recapitulated basic in  vivo 
hepatic functions and structure, whilst maintaining 
specific parameters required for multiple biochemical 
endpoint testing [28, 29]. Applying this liver model, a 
range of five different ENMs were evaluated, across a 
low concentration range of 0.2–10.0  µg/mL, to deter-
mine whether the individual physico-chemical char-
acteristics would elicit a different biological response 
following either an acute (24 h) or longer-term (120 h) 
exposure scenario in  vitro. A low-dose concentration 
range was selected to not only simulate physiologi-
cal relevant concentrations of translated ENMs in the 
liver, but to ensure that the in  vitro test system is not 
over saturated by the sheer volume of material, which 
increases the risk of a misleading positive toxicity result 
[14, 15].
Previously, many in  vitro studies have focused on the 
acute effects of high concentrations of ENMs [17, 40]. 
Acute exposure regimes are a less laborious and generally 
a more efficient way to quickly determine whether a sub-
stance has the potential to illicit an adverse reaction or 
be hazardous. However, it does not provide an accurate 
representation of the prolonged effects this acute expo-
sure may have nor does it provide any indication of the 
accumulated effects were this exposure to be a recur-
ring event. In order to address this, a longer-term expo-
sure regime of five days (120 h; bolus and repeated) was 
established to provide a more realistic dosing scenario, as 
most individuals are likely to be exposed to multiple, low 
doses of ENMs over time [17, 41]. Alongside the evalu-
ation of key toxicological endpoints, such as cytotoxic-
ity, (pro-)inflammatory response and genotoxicity, the 
viability and fidelity of the liver model had to be assessed 
throughout the duration of this study. As biomarkers of 
hepatic metabolism and functionality, albumin and urea 
production were measured. Albumin is a stable, 66.5 kDa 
plasma protein primarily synthesised in the liver and is 
principally responsible for maintaining oncotic pressure 
within in the blood, in order to prevent excess volumes 
of water being leaked into the surrounding tissues [42]. 
In addition to this, albumin has been found to play a role 
in immunomodulation, antioxidant effects and binding 
to multiple drugs, toxins, and other molecules, includ-
ing ENMs. Albumin is one of the most abundant proteins 
frequently found in the protein corona of ENMs [43, 44]. 
Urea is an organic, 60 Da, metabolic end product of pro-
tein catabolism; a process which happens within the liver 
as it is the sole organ that has enzymes for urea synthe-
sis [45]. Urea synthesis is crucial in the breakdown and 
excretion of nitrogen waste products, such as ammonia, 
which are toxic to the mammalian body if not metabo-
lised to urea and excreted as urine [46]. Across all acute 
ENM exposures, the viability and liver functionality was 
not significantly reduced, with the exception of exposure 
to the top concentrations (5.0  µg/mL and 10.0  µg/mL) 
of Ag and  BaSO4 which did significantly reduce albu-
min production. As this reduction was not mirrored in 
the production of urea, one suggestion for this decrease 
could be the tendency of ENMs to actively adsorb pro-
teins, like albumin, to their surface as part of the pro-
tein corona; the reduction may therefore be an artifact 
[47, 48]. Over the duration of the prolonged exposures, 
as expected, the albumin levels increased as a result of 
the actively proliferating cells on the outer layers of the 
spheroid. Subsequently, the higher prevalence of albumin 
could saturate the ENM corona and so the previously 
observed decrease in albumin may have been compen-
sated for. Overall, neither acute nor prolonged exposure 
to these test ENMs significantly reduced the fidelity of 
(See figure on next page.)
Fig. 2 Release of IL‑8 (pro‑)inflammatory cytokines in 3D HepG2 liver spheroids following both acute (24 h) and longer‑term (120 h) exposure to 
0.2–10.0 µg/mL of (A)  TiO2, (B) ZnO, (C) Ag, (D)  BaSO4 and (E)  CeO2 ENMs. An untreated, media only sample was used as the negative control. The 
positive assay control was 0.25 µg/mL of TNF‑α protein (NBP2‑35076‑50 µg, Biotechne, UK), as indicated by the dotted line, which represents the 
mean positive control response for both acute (light red line) and prolonged (dark red line) exposures. Mean data of three biological replicates, 
analysed in triplicate (n = 9) are presented ± SEM. Significance is indicated in relation to the negative control, where * = p ≤ 0.05 
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Fig. 2 (See legend on previous page.)
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these HepG2 spheroids, which also correlates with the 
limited cytotoxicity observed over the concentration-
ranges and exposure regimes applied.
Each ENM has a unique set of physico-chemical char-
acteristics (e.g. size, shape, composition, surface charge, 
coating, crystallinity and solubility) which determine 
how these materials interact with biological systems; 
influencing cellular uptake, bio-durability, transloca-
tion and deposition around the body [49]. Not only is it 
important to fully characterize an ENM prior to expo-
sure, it is equally as important to characterize these 
materials under biological exposure conditions as these 
materials may undergo transformation (e.g. dissolution, 
aggregation and reprecipitation) when they come into 
contact with different biological fluids [39]. As a result, 
these novel size-specific characteristics often heavily 
influence the toxicological potential for such materials. 
Therefore, it is particularly important to consider the 
physico-chemical characteristics and biotransformation 
potential of these materials when evaluating the toxicity 
outcomes observed.
Many ENMs are known reactive oxygen species (ROS)/
reactive nitrogen species (RNS) inducers, and directly or 
indirectly cause an imbalance in the redox homeostasis 
of the cell [50–52]. Most metal based ENMs, particu-
larly transition metals, elicit ROS and free radical medi-
ated toxicity via Fenton-type reactions. As a result, their 
ability to influence intracellular calcium concentrations, 
activate (pro‐)inflammatory transcription factors (e.g., 
nuclear factor kappa B [NF‐kB]) and modulate cytokine 
release via the production of free radicals, is believed to 
be linked to the greater surface area, therefore increased 
surface reactivity, as well as the addition of pro-oxidant 
thiol groups on the surface of the materials [50–52]. 
Interestingly, the ENM with greatest surface area  (TiO2) 
did exhibit the greatest  O2 reactivity and induced the 
greatest IL-8 response over any other material, with a 
significant increase in IL-8 release observed following 
acute exposure to 0.50  µg/mL. This was no longer the 
case following prolonged exposures. Instead, as the con-
centration of  TiO2 increased in the prolonged exposure 
studies, the concentration of IL-8 decreased. This may 
be attributable to the increased agglomeration observed, 
restricting cellular uptake and reducing the surface area 
available for oxidative reactions to occur. In addition, the 
likelihood is that any REDOX or Fenton-type reactions 
will have occurred within the first 24 h of the exposure. 
As a result, the production of free radicals that trigger the 
release of (pro-)inflammatory cytokines, like IL-8 via the 
activation of REDOX sensitive Nf-kβ or MAPK signalling 
pathways, may no longer be as actively expressed 120 h 
later. The differences in ENM associated IL-8 release 
between acute and prolonged exposures could suggest 
that other factors (e.g. dissolution, agglomeration, rate 
of cellular uptake) may be more influential in orchestrat-
ing the (pro-)inflammatory response during this time. It 
appears the two materials (Ag and ZnO) with the great-
est solubility and lowest surface area, exhibit minimal 
dose-dependent effects in IL-8 release, with a consistent 
IL-8 response observed across almost all doses following 
either an acute or prolonged exposure. In contrast, ENMs 
with a more bio-persistent nature, which take longer to 
breakdown and clear, could cause a greater and more 
variable inflammatory response in the prolonged expo-
sure. For example,  BaSO4, induced the only significant 
increase in IL-8 release following prolonged exposure. 
The overall increase in IL-8 release observed between the 
acute and prolonged ENM exposures is likely caused by 
the reduced oxygen diffusion towards the centre of the 
spheroid over time. This will result in increased hypoxic 
conditions within the spheroid core, which is associated 
with increased IL-8 production [29, 53–55].
Genotoxicity of the five test ENMs was assessed using 
the ‘gold standard’ in  vitro MN assay, which is the rec-
ommended test for evaluating fixed gross chromo-
somal damage for regulatory purposes. Whilst there is 
an OECD Test Guideline (TG487) for this assay, it has 
long been recognised that nano-specific adaptations to 
the method are required, which were included in the 
approach taken within this study [56, 57]. No significant 
cytotoxicity was detected following either acute or pro-
longed exposure to any of the ENMs tested, regardless of 
the concentration or dosing regimen employed. However, 
all five ENMs tested positive for genotoxicity following 
acute exposure, albeit not in a dose-dependent manner, 
due to variation in agglomeration across dose ranges. A 
genotoxicity potency ranking was established based on 
the dose response and the greatest fold-change in MN 
Fig. 3 Cytotoxicity and genotoxicity responses in HepG2 spheroids following both acute (24 h) and prolonged (120 h) exposure to 0.2–10.0 µg/
mL of (A)  TiO2, (B) ZnO, (C) Ag, (D)  BaSO4 and (E)  CeO2 ENMs. Cytotoxicity was assessed using the cytokinesis‑block proliferation index (CBPI) for 
acute exposures, whilst trypan blue was assessed for the prolonged exposures, both of which are presented relative to the negative, untreated 
control. A known liver carcinogen, aflatoxin B1 (0.1 µM) was used as a positive control for genotoxicity. For acute exposures, 1000 binucleated 
cells were scored per replicate for each dose point using the cytokinesis‑block version of the MN assay (2000 binucleate cells scored in total per 
dose). For prolonged exposures, 2000 mononucleated cells were scored per replicate for each dose point using the mononuclear MN assay (4000 
mononucleate cells scored in total per dose). Mean data of two and three biological replicates (n = 2, n = 3) for genotoxicity and cytotoxicity 
respectively is presented ± SD. Significance indicated in relation to the negative control: * = p ≤ 0.05 
(See figure on next page.)
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induction, as follows: ZnO >  TiO2 >  BaSO4 =  CeO2 > Ag. 
This genotoxicity potency ranking could help provide 
an insight into the DNA damaging potential of these 
ENMs if exposed to the human liver. However, it is also 
important to note that whilst for each material there is 
evidence of genotoxicity, there is also evidence of dose 
ranges where DNA damage does not occur and so there 
may be opportunity for safe exposure limits to be estab-
lished. The average LOAEL post-acute exposure was 
induced by an ENM concentration of 0.5  µg/mL, with 
ZnO,  BaSO4,  CeO2 and Ag eliciting a 2.75-, 1.54-, 1.51- 
and 1.37-fold change in MN induction, respectively. 
For,  TiO2, whilst the LOAEL was reached at 2.0  µg/mL 
with 1.83-fold increase in MN frequency over control, 
this material induced the second greatest increase in 
MN induction behind ZnO, with a 2.4-fold increase in 
MN fold following acute exposure to 5.0  µg/mL. The 
significant increase in MN induction following acute 
24  h exposure to higher concentrations of  TiO2, could 
be attributed to the high oxidative potential  TiO2 exhib-
its within the first 24 h of exposure, Fig. 1B. This potent 
 O2 reactivity suggests that the elevated DNA damage 
observed could be a result of ROS and oxidative stress. 
DNA is one of the major targets for oxidative stress 
induced damage (e.g. DNA–protein crosslinks, alkali-
labile sites, DNA adducts, mutations), with  OH•, a highly 
Fig. 4 Schematic representation of the prolonged (120 h) single, bolus ENM exposure regime and the fractionated, repeated ENM exposure 
regime assessed using 3D HepG2 spheroids and key biochemical endpoint analysis techniques selected. A Colourmetric based assay for albumin 
quantification. B CellSens X63 image displaying binucleate formation following the cytokinesis‑block micronucleus (CBMN) assay with the presence 
of a micronucleus. C (Pro)‑inflammatory ELISAs for Interleukin 8 (IL‑8), Interleukin‑6 (IL‑6) and Tumor Necrosis Factor Alpha (TNF‑α). Created with 
Biorender.com
Table 5 Concentration of albumin and urea produced per HepG2 spheroid following a prolonged (120 h) exposure using a 
single, bolus dosing regime or a fractionated, repeated dosing regime with 0.5 and 5.0 µg/mL of  TiO2 and ZnO ENMs
Mean data of three biological replicates, analysed in triplicate (n = 9) are presented with 95% confidence intervals. Significance is indicated in relation to the negative 
control, where * = p ≤ 0.05
3D HepG2 liver spheroid liver 
functionality
Albumin per spheroid (ng/µL) (95% CI) Urea per spheroid (ng/µL) (95% CI)
Dosing regime employed Bolus Fractionated Bolus Fractionated
Untreated negative control 32.807 (29.323–36.291) 0.805 (0.729–0.880)
TiO2
0.5 µg/mL
37.736 (29.973–45.499) 33.716 (30.426–37.007) 0.885 (0.722–1.048) 0.806 (0.616–0.995)
TiO2
5.0 µg/mL
32.740 (29.457–36.022) 31.289 (25.383–37.195) 0.818 (0.757–0.878) 0.815 (0.772–0.858)
ZnO
0.5 µg/mL
42.960 (30.320–55.601) 32.948 (28.644–37.252) 0.790 (0.585–0.996) 0.819 (0.781–0.858)
ZnO
5.0 µg/mL
33.971 (31.280–36.662) 36.665 (33.365–39.965) 0.854 (0.775–0.932) 0.666 (0.492–0.840)
Aflatoxin B1 positive control 35.969 (25.594–46.344) 36.978 (30.590–43.366) 0.769 (0.707–0.885) 0.792 (0.758–0.826)
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potent free radical, known to react with all components 
of DNA and causing strand breaks via the formation of 
8-OHdG DNA adducts [58, 59]. Whilst  TiO2 ENM  O2 
reactivity is very active during the first few hours of the 
exposure, this oxidative potential appears to decrease as 
exposure duration increases and so may no longer be as 
prominent following prolonged exposure, resulting in the 
lower MN frequency at 120 h. In all cases, the top dose of 
10.0 µg/mL resulted in a lower MN frequency following 
acute exposure than that of the former dose of 5.0 µg/mL. 
This is most likely due to greater material agglomeration 
at the top dose, restricting ENM translocation through 
the compact spheroid structure, thus reducing cellular 
uptake and biological interaction. It is well known that at 
higher ENM concentrations, the degree of agglomeration 
tends to be greater than that at the lower concentrations 
of ENMs, as the high number of particles within a given 
space increases the chance of particle–particle interac-
tion and subsequent agglomeration [60]. This was further 
illustrated in this study by the time- and dose-dependent 
increase in agglomeration, with the average agglomer-
ate size increasing from 23 nm at 0.2 µg/mL to 282 nm 
at 10.0  µg/mL, and 37  nm at 0.2  µg/mL to 275  nm at 
10.0  µg/mL, respectively (Table  2). Whilst, at the low-
est concentration of 0.2  µg/mL, all five ENMs remain 
monodispersed following acute exposure and only small 
agglomerates (< 80 nm) had formed over the duration of 
the 120 h exposure. At lower doses, darkfield imaging of 
PHH microtissues following exposure to 1.25 µg/mL and 
5.0 µg/mL of  TiO2 (NM-105) and  CeO2 (NM-212), illus-
trated that the ENMs could penetrate deep into the core, 
with a large proportion of the hepatocytes encountering 
the ENM [14]. This is further supported with evidence 
that the microtissues were shown to rotate within the 
wells, and thus ENM exposure is likely to be even across 
the surface of the spheroids [14]. Similarly, with the addi-
tion of an agarose coating at the base of the spheroids, 
the HepG2 spheroids are also free to move and rotate 
within the well enabling the ENMs to access the entire 
surface layer of actively proliferating HepG2 cells [28].
There was a significant difference in the genotoxicity 
observed between acute and prolonged ENM exposure, 
whereby the notable ENM-associated genotoxic effects 
observed in the first 24 h are not apparent over the pro-
longed exposure. This could be due to repair mechanisms 
that, may be efficient at removing DNA damage and / or 
damaged cells over time, which is not evident in an acute 
exposure experiment. Additionally, cells developing MN 
within the first 24 h of exposure can undergo cell death 
over the remaining duration of the prolonged experi-
ment. It is also important to consider that following the 
prolonged exposure periods, although more individual 
Fig. 5 Release of IL‑8 (pro‑)inflammatory cytokines in 3D HepG2 
liver spheroids following a prolonged (120 h) exposure using a 
single, bolus dosing regimen or a fractionated, repeated dosing 
regimen with 0.5 and 5.0 µg/mL of  TiO2 and ZnO ENMs. An untreated, 
media only sample was used as the negative control whilst 0.25 µg/
mL of TNF‑α protein (NBP2‑35,076‑50ug, Biotechne, UK) was used 
as the positive assay control, as indicated by the red dotted line 
which represents the mean positive control response. Mean data 
of three biological replicates, analysed in triplicate (n = 9) are 
presented ± SEM. Significance indicated in relation to the negative 
control: * = p ≤ 0.05 
Fig. 6 Cytotoxicity and genotoxicity responses in HepG2 spheroids 
following a prolonged (120 h) exposure using a single, bolus dosing 
regimen or a fractionated, repeated dosing regimen with 0.5 and 
5.0 µg/mL of  TiO2 and ZnO ENMs. Cytotoxicity was assessed using 
the trypan blue exclusion assay and is presented relative to the 
negative, untreated control. A known liver carcinogen, aflatoxin B1 
(0.1 µM) was used as a positive control for genotoxicity. For acute 
exposures, 1000 binucleated cells were scored per replicate for each 
dose point using the cytokinesis‑block version of the MN assay (2000 
binucleate cells scored in total per dose). For prolonged exposures, 
2000 mononucleated cells were scored per replicate for each dose 
point using the mononuclear MN assay (4000 mononucleate cells 
scored in total per dose). Mean data of two and three biological 
replicates (n = 2, n = 3) for genotoxicity and cytotoxicity respectively 
is presented ± SD. Significance indicated in relation to the negative 
control: * = p ≤ 0.05 
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cells were scored in the analysis, there is a greater 
chance of the DNA damage observed in the first 24  h 
to have been “diluted” in the ever-growing population. 
As a result, the probability of scoring a cell with a MN 
decreases over time. However, these time-dependent dif-
ferences in genotoxicity could also be as result of extrinsic 
ENM physico-chemical properties (e.g. surface reactivity, 
agglomeration and dissolution). For example, ZnO was 
the only ENM to exhibit genotoxic effects following both 
acute and prolonged ENM exposure, with a significant 
response induced at 0.5–10.0  µg/mL in the acute expo-
sures and 0.2–5.0  µg/mL in the prolonged exposures. 
ZnO nanoparticles are known to be highly soluble and 
readily release ions [61]. Aligned with existing literature, 
the ZnO ENMs in this study were found to rapidly dis-
solve into  Zn2+ ions and two hydroxide ions, the latter 
causing an increase in pH in the culture medium within 
15 min of exposure [37]. For soluble metal ENMs, there 
is always a question as to whether the toxicity observed 
is caused directly by the ENMs themselves or from 
the dissolved ions. ZnO ENMs can dissolve into  Zn2+ 
ions, which can trigger signaling cascades leading to an 
enhanced influx of calcium, the release of (pro-)inflam-
matory mediators and ROS generation [40]. Interestingly, 
the greater induction of genotoxicity was observed fol-
lowing 24 h exposure to ZnO ENMs as opposed to 120 h. 
This is hypothesized to be induced by the rapid dissolu-
tion of  Zn2+ ions within the first 24  h, inducing acute 
adverse effects similar to those described above, leading 
to an elevated genotoxic effect which was no longer as 
prominent following 120  h exposure, as a result of the 
reduced number of ions released over the 120  h expo-
sure period. This correlates with reports in the literature 
whereby, an acute 24 h ZnO (NM-111) exposure caused a 
loss in the glutathione levels and an increase in the levels 
of ROS in the human hepatoblastoma C3A cell line [62]. 
Further to this, by employing the anti-oxidant Trolox, 
a reduction in IL-8 response and a suppression in the 
toxicity potential of the ZnO ENMs was observed, thus 
highlighting the important link of ZnO mediated oxida-
tive stress. This elevated ZnO induced oxidative stress 
and ROS, has been shown to cause oxidative DNA dam-
age, including DNA strand breaks and formamidopyrimi-
dine DNA glycosylase (fpg)-specific DNA lesions in the 
liver [63, 64]. In addition, there are concerns that even if 
ZnO ENMs were not able to enter the nucleus, the  Zn2+ 
ions could interact and affect DNA integrity, making suc-
cessful DNA repair even more challenging [40]. These 
reports in the scientific literature indicate that persistent 
release and accumulation of ions over time could further 
induce ongoing oxidative stress and ROS induced DNA 
damage, as well as impeding DNA repair mechanisms, 
resulting in a prolonged genotoxic effect, similar to that 
found in this study.
Although Ag ENMs release  Ag+ ions in a similar man-
ner to ZnO, the Ag were found to be the least genotoxic 
out of the five materials tested. It is possible these  Ag+ 
ions may also induce DNA damage, but they are released 
much more slowly than the  Zn2+ ions; thus, it is hypoth-
esized that the gradual dissolution of Ag ENMs over the 
24  h period could allow time for the repair of any low 
level damage induced. Additionally, the Ag ENMs were 
found to exhibit substantial dose-dependent agglom-
eration, with almost a 12-fold increase in the average 
particle diameter between the lowest and the highest 
concentrations, which could restrict the number of Ag 
particles internalized by the hepatocytes. Any Ag ENMs 
not internalized by the cells would remain within the 
culture medium and subsequently dissolve into Ag ions 
in situ, where the ions would likely be sequestered by the 
excess serum proteins in the medium. Consequently, the 
extrinsic physico-chemical variances between ZnO and 
Ag ENM are likely to account for the differences in their 
ability to induce genotoxicity.
Due to the more prominent genotoxic nature of ZnO 
and  TiO2, these two materials were taken forward for 
further assessment into the effects different prolonged 
exposure regimes may have upon the genotoxic potential 
of ENMs. It was important to test both materials, as ZnO 
was known to give a positive genotoxic response follow-
ing both acute and prolonged exposures, whilst  TiO2 only 
induced genotoxicity after an acute exposure. Interest-
ingly, the enhanced complexity of the repeated exposure 
regime, developed to better mimic the natural human 
exposure scenario, made no difference on the toxicologi-
cal response (cytotoxicity, (pro-)inflammatory response 
nor genotoxicity) in the HepG2 liver spheroids. A previ-
ous study, using the same materials, ZnO (JRC NM-111) 
and  TiO2 (JRC NM-105), showed that a repeated expo-
sure of 0.62–10.0 µg/mL dosed every other day for up to 
21 days induced limited cytotoxicity, but a time depend-
ent increase in cytokine levels in PHH microtissues 
[14]. Kermanizadeh et  al., however, did not fractionate 
the doses over this time period and also included a 24 h 
recovery period between doses and an extended recov-
ery (≥ 7 days) at the end of the exposure duration, which 
was shown to help alleviate the (pro-)inflammatory 
response. In that study, whilst an almost complete refresh 
of the culture medium was undertaken between repeated 
exposures, as the doses were not fractionated the final 
concentration of the ENM exposures will have been 
greater than those used in the present study as a result 
of residual material. Consequently, even with a repeated 
ENM exposure regime that is four-fold longer than the 
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one described in the present study, neither  TiO2 or ZnO 
induced any adverse effects in either hepatic model. This 
could be explained through the liver’s unique ability to 
regenerate itself following acute toxicological insult, and 
with the low doses used for the repeated exposure in 
this study, toxicity may have been within limits that did 
not overwhelm the hepatocytes nor induce adverse out-
comes. Another aspect to consider is whether the added 
complexity of a prolonged, repeated exposure outweighs 
the benefits of a more simplistic dosing approach. In the 
present study, the added complexity of repeated, fraction-
ated exposures did not improve the predictive capabilities 
of the in vitro 3D liver model when evaluating ZnO and 
 TiO2. Thus, while prolonged repeated ENM exposures 
performed with in vivo relevant concentrations are more 
physiologically relevant and provide a better insight into 
the long-term effects of ENM exposure upon the liver, 
fractionated, repeated dosing regimens may not provide 
additional benefit for assessing the toxicological response 
in hepatocytes over single, bolus dosing regimens.
Conclusion
In conclusion, both acute and prolonged ENM expo-
sures were assessed and were shown to result in dif-
ferent toxicological responses. This highlights the 
importance of evaluating prolonged ENM exposures 
to fully understand the longer-term and accumulated 
effects of  ENMs following acute insult. For ZnO and 
 TiO2, there was no significant difference between pro-
longed single, bolus or repeated, fractionated exposure 
regimes. Thus, the added complexity of fractionated 
dosing did not influence the study outcome. Even 
given the low doses of ENM applied in this study, 
all five of the materials tested were shown to induce 
fixed DNA damage in 3D HepG2 spheroids following 
acute exposure, leading to the following genotoxic-
ity potency ranking: ZnO >  TiO2 >  BaSO4 =  CeO2 > Ag. 
This study therefore demonstrates that 3D in  vitro 
hepatic spheroid models have the capacity to be uti-
lised for evaluating more realistic ENM exposures, 
thereby providing a future in vitro approach to better 
support ENM hazard assessment in a routine and eas-
ily accessible manner.
Materials and methods
In vitro 3D liver model
The Human Caucasian Hepatocellular Carcinoma 
derived epithelial cell line, HepG2 (ECACC 85011430 
and ATCC HB-8065) monolayers were cultured in 
Dubecco’s Modified Eagle Medium (DMEM) with 
4.5g/L d-Glucose and L-Glutamine (GIBCO, Paisley, 
UK) supplemented with 10% Foetal Bovine Serum 
(FBS) and 1% Penicillin/Streptomycin antibiotic 
(GIBCO, Paisley, UK). HepG2 cells were sub-cultured 
every 3–5 days, once 80% confluency was reached, 
they were trypsinised (0.05% trypsin/EDTA solution; 
GIBCO, Paisley, UK) and a cell stock of 2.0 ×  105 cells/
mL was prepared. To form the 3D spheroid structure, 
HepG2 cells were cultured in 96-well plates using the 
hanging drop method developed by Llewellyn et al. and 
described by Conway et al. [28, 29]. Extensive informa-
tion regarding the establishment, culture, characterisa-
tion, exposure protocol, harvest and application of the 
3D HepG2 spheroid model can be found in the pub-
lished protocol by Llewellyn et  al., 2020. In short, 20 
μL of the cell suspension (4000 HepG2 cells per 20 μL 
hanging drop) was pipetted onto the inverted side of 
a 96-well tissue culture plate, before gently inverting 
the lid and placing back onto the 96-well plate filled 
with 100µl of PBS [28]. The plate was then placed in 




Powder samples were loaded onto a 20 × 20 mm glass 
sample holder, and the incident X-rays aligned to enter 
the centre of the sample. The X-ray is generated by a 
rotating anode X-ray generator of Copper (Cu). We 
executed a 2θ−θ coupled scan from 10  °C to 100  °C 
with a step width of 0.02 °C and a second duration time 
per step. Measured data is refined by Rietveld analysis 
using PDXL from Rigaku SmartLab. XRD analysis were 
performed in line with ISO 17025 and, technically to, 
JIS K 0131 and BS EN 13925-4 [65–67].
Impurities (XRF)
Semi-quantitative elemental analysis was conducted on 
powder samples of the ENMs using a Bruker S8 Tiger 
wave length dispersive X-ray fluorescence (WDXRF) 
spectrometer using Rh X-ray source operated at 60 
kV. Powdered samples of 2.0–5.0 mg were placed on 
a XRF thin film (mylar sheet with a thickness of 6.0 
µm), which was fixed in a 40 mm diameter sample cup 
(Fluxana, Kleve, Germany). The measurement time was 
17 min. Results were manually post-processed for each 
element individually, to account for low concentrations 
and peak overlaps.
TEM (size, 3D aspect ratio and circulatory)
TEM was carried out for ENMs on an EM208, operat-
ing at 200 kV (Philips, Eindhoven, The Netherlands), 
with a high definition acquisition system based on a 
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side-mounted TEM camera OSIS Morada and an iTEM 
soft-ware platform (Olympus Soft Imaging Solutions 
GmbH, Münster, Germany). ENMs, dispersed in MilliQ 
water, were placed onto a carbon-coated grid and dried 
at room temperature under vacuum.
Surface area (BET)
Specific surface area was determined with the BET 
method using a Micromeritics Gemini V. Samples were 
degassed at 100  °C under vacuum for 30 mins. Nitro-
gen adsorption isotherms at 77 K were recorded at five 
pressures between 0.05 and 0.30 P/P0. Measurements 
were performed adhering to the standard DIN ISO 
9277-2014-01 [68].
Density (He pycnometer)
Skeletal density of all ENMs was determined using a He 
pycnometer (Micromeritics AccuPyc II 1340). Samples 
were measured at 20 °C, applying ten He purging cycles 
of the chamber before the measurement and analyzed 
according to DIN EN ISO 1183-3 [69].
XPS
XPS measurements were performed with a VersaProbe II 
Spectrometer (Ulvac-Phi, Japan) to obtain the chemical 
composition. The instrument was calibrated with clean 
Gold (Au) and Cu foils, of which electron binding ener-
gies were Au 4f=83.96 ± 0.02 eV and Cu  2p3/2= 932.62 
± 0.05 eV, respectively [70]. The samples were irradi-
ated with monochromatic Al Kα X-ray (ħω=1486.6 eV, 
25 W) using an X-ray spot size of 100 × 100 μm2 and a 
take-off angle of 45 º with respect to the sample surface. 
The base pressure of the instrument was better than 1.0 
×  10-9 Torr and the operating pressure better than 3.0 
×  10-9 Torr. The surface chemical compositions (as %) 
were determined by relative atomic sensitivity factors. 
The samples were not etched or pre-treated prior to each 
measurement.
Surface charge
The zeta potential (ZP) was measured at room tempera-
ture (25 °C) as a function of pH using a ZP analyzer (Mal-
vern Zetasizer Nano ZS). Each ZP value was calculated 
in an average of 22–30 runs at pH 7 in 10 mM potassium 
chloride (KCl) water solution.
FRAS
For ENM reactivity testing under physiological condi-
tions, the FRAS assay multi-dose protocol was under-
taken as described by Gandon et al. [71].
EPR spin trap DMPO and CPH
Two standardized EPR methods have been established to 
assess the surface-induced reactivity of ENMs: method 
I utilizes the nitrone spin trap DMPO, one of the most 
established spin traps for nanosafety purposes, whilst 
method II employs the cyclic hydroxylamine spin probe 
CPH which interacts directly with short-lived ROS (e.g. 
superoxide radical) on the material surface [72, 73].
Hydrophobicity
The material hydrophilicity was evaluated by a water 
contact angle measurement using Drop Shape Ana-
lyzer - DSA100. Sample powder (~ 0.5 g) was spread as 
a thin layer on the surface of the sticky sample holder 
(3M Color Laser Transparency Film plate covered with 
a homogenous adhesive layer (0.25 mm) of  Acronal® 
V 215) by pressing the surface with a spatula. A nitro-
gen gun is used to gently blow the powder residuals not 
attached to the sample holder’s surface. Finally, contact 
angle measurement was performed at 23  °C by measur-
ing the diameter of the spherical crown of 2 μL water 
dropped on the surface of sample layer.
Dynamic light scattering (DLS)/electrophoretic light 
scattering (ELS) measurements
The colloidal characterization of  TiO2, ZnO, Ag,  BaSO4 
and  CeO2 ENMs was determined using a Zetasizer nano 
ZSP (model ZEN5600, Malvern Instruments, UK), meas-
uring the DLS (ØDLS) and ZP of nanosol. ZP measure-
ments were performed by ELS and the Smoluchowski 
equation was applied to convert the electrophoretic 
mobility to ZP. ENMs were diluted at 0.2, 0.5, 1.0, 2.0, 
5.0 and 10.0 µg/mL in DMEM complete for DLS and ZP 
analysis and measured after 24 and 120 h of exposure at 
37  °C in static condition. Samples were measured three 
times and the mean ØDLS and ZP data presented.
Sensor dish reader reactivity and Dissolution testing
Real-time temporal pH and  O2 reactivity and 24 h end-
point dissolution testing was performed using the Sensor 
 Dish® reader (SDR) method (PreSens Precision Sensing 
GmbH, Regensburg, Germany). The test is based on the 
use of fluorescent pH (HydroDish™; range: pH 6–8.5, res-
olution 0.05 pH units) and  O2 (OxoDish™; range: 0–50% 
dissolved  O2; measured in mmol/L) sensors mounted at 
the bottom of each well in 24-well multi-dish cell incuba-
tion plates. The tests were conducted in DMEM + 10% 
FBS + 1% Pen/Strep, similar to the medium used in the 
in vitro assays. A standard material concentration of 320 
µg/mL was used to obtain sufficiently robust reactivity 
signal from the test materials as compared with the reac-
tivity signal from the pure medium.
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Batch-dispersions of 2.56 mg/mL were made in 0.05% 
BSA-water by 16 min, 13 mm probe-sonication, ampli-
tude 10% (Branson Sonifier S-450D, Branson Ultrason-
ics Corp., Danbury, CT, USA) after pre-wetting the test 
materials with ethanol following the NANOGENOTOX 
dispersion protocol [74] and added by pipette to the test 
media immediately after dispersion was completed.
For each test,  SensorDish® plates with 1.750 mL test 
medium added to each well were placed on the plate 
readers in a cell incubation chamber (37  °C; 5%  CO2 
atmosphere; 95% Relative humidity;  CelCulture®  CO2 
Incubator, ESCO Medical, Egaa, Denmark). After ther-
mal equilibration to 37  °C, a batch dispersion was pre-
pared for the test material in question. 250 µL batch 
dispersion or control dispersion medium were each 
added to half of the wells, respectively and online meas-
urement of the pH and  O2 concentrations was started 
immediately. After 24 h the measurements were stopped 
and medium samples were collected and added to 3 kDa 
centrifugal filter tubes by pipette and centrifuged at 4000 
× RCF for 30 min. The 3 kDa filtered medium were sam-
pled and added 500 µL 2% ultrapure  HNO3. The amount 
of liquids were weighed for subsequent quantification. 
Liquid samples were stored in darkness until shipment 
for inductively coupled plasma mass spectrometry (ICP-
MS) analysis. The temporal reactivities (dpH and  dO2) 
were calculated as the difference between the mean val-
ues in wells with a test material minus the mean values in 
wells without a test material and then plotted as function 
of time. The SDR-test is explained in detail in Jørgensen 
et al. (in prep.)
ENM exposures
Five ENMs  (TiO2 NM-105, ZnO NM-111, JRC Nano-
materials Repository, Belgium;  BaSO4 NM-220,  CeO2 
NM-212, Fraunhofer IME, Germany; and Ag 576832, 
Sigma Aldrich, UK) were stored as dry powders at room 
temperature until the day of exposure. ENM stock solu-
tions were prepared (2.56 mg/mL) and dispersed for 16 
mins in 0.05% Bovine Serum Albumin (BSA) using the 
probe sonication (Branson Sonifier 250, Ø 13 mm, 400 W 
output power, 20 kHz) method described by Jensen et al. 
[74]. Working stocks of ENMs were made fresh for each 
experiment. Following dispersion, ENMs were diluted 
in cell culture media to the required concentrations 
with all five ENMs assessed over both an acute 24 h and 
prolonged 120 h exposure scheme. For prolonged ENM 
exposures, a partial media change was undertaken after 
72 h, whereby the top 50% of the culture medium within 
the wells was removed and replaced with fresh ENM-free 
culture medium of the exact same volume. Exposure pro-
cedures are described in detail, with a peer-reviewed SOP 
available, in Llewellyn et  al. [29].  TiO2 and ZnO at two 
selected doses of 0.5 and 5.0 µg/mL, were further evalu-
ated following a longer-term (120 h), repeated dosing 
scheme whereby the original bolus dose was fractionated 
into five, equal parts of 0.1 and 1.0 µg/mL, respectively 
to be dosed daily onto the 3D liver spheroids, Fig.  4. 
The plates were then incubated at 37 °C/5%  CO2 for the 
desired exposure period. For prolonged exposures, a cul-
ture medium replacement was undertaken once, on Day 
3 of the exposure, by removing 50 µL of media from the 
well and replacing with a fresh 50 µL of DMEM. For the 
repeated ENM exposures however, this was not neces-
sary, as 50% of the culture medium was being refreshed 
daily with the new dose of ENMs. All experiments were 
performed with three biological replicates with mean 
data ± SD presented, unless stated otherwise.
Liver functionality: albumin and urea assays
Following both acute and prolonged ENM exposure, 
liver-like functionality was evaluated using the BCG 
Albumin Assay Kit (MAK124, Sigma, UK) and Urea 
Assay Kit (MAK006, Sigma-Aldrich, UK). A negative, 
untreated media control was used alongside a chemi-
cal positive control; 0.1 µM of a known liver carcinogen, 
Aflatoxin B1 (Afla B1; Cat# No: A6636, Sigma Aldrich, 
UK). At the end of the exposure period all supernatants 
were harvested by pooling 50 µL of media from each 
well. To sediment any excess ENM from the superna-
tant, the samples were centrifuged at 230g for 2 mins 
and the resulting supernatant collected. All assays were 
performed as per manufacturer’s instructions, with three 
biological replicates assessed in triplicate. For the urea 
assay, supernatants were diluted 1:10 with urea assay 
buffer.
(Pro)‑inflammatory response: interleukin‑6 (IL‑6), 
interleukin 8 (IL‑8) and tumour necrosis factor alpha 
(TNF‑α)
Cytokine release was quantified by ELISA, using the 
cell supernatants described above. DuoSet human anti-
body kits for IL-8, IL-6, and TNF-α (DY208, DY206 and 
DY210 DuoSet ELISA, R&D Systems) were used accord-
ing to the manufacturer’s instructions. An ELISA assay 
positive control, Tumor Necrosis Factor Alpha Protein 
(TNF-α protein; Cat# No: 2-35076, BioTechne, UK) was 
re-suspended in  ddH2O according to manufacturer’s 
instructions and diluted to a final working concentration 
of 0.25µg/mL of TNF-α protein. The detection antibodies 
were diluted as follows: IL-8: 0.1% BSA, 0.05% Tween 20 
in Tris-buffered Saline (TBS) and IL-6/TNF-α: 1% BSA in 
PBS, and incubated with samples for 2 h at RT. The signal 
was developed using streptavidin horseradish-peroxidase 
and TMB Substrate Reagent A and B (Cat# No. DY999, 
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R&D Systems, UK). Absorbance was measured at 450 
nm (PolarStar Omega Plate Reader) and the standard 
curve was plotted as 4-parameter logistic fit using the 
MyAssays.com software. Three biological replicates were 
assessed in triplicate.
Cytotoxicity and genotoxicity: trypan blue exclusion assay, 
cytokinesis proliferation index and in vitro micronucleus 
assay
The MN assay was undertaken in conjunction with 
the cytokinesis-block proliferation index (CPBI) and 
trypan blue exclusion assay for determining cytotoxic-
ity post-acute and longer-term ENM exposures, respec-
tively. A negative, untreated media control was used 
alongside 0.1 µM of a known liver carcinogen, Afla B1 
as a positive control for genotoxicity. The MN assay was 
conducted as described by Conway et al. [28]. In short, 
after both acute and prolonged exposures, the cell cul-
ture supernatant was harvested and stored at –  80  °C 
for future biochemical endpoint analysis. The remain-
ing liver spheroids were then pooled, trypsinised and 
prepared for cytotoxicity assessment and semi-auto-
mated MN scoring as previously described by Llewellyn 
et al. and Conway et al. [28, 29]. When scoring, detec-
tion of micronuclei in bi-nucleated or mono-nucle-
ated cells were performed as previously described by 
Llewellyn et al. [29]. A minimum of 1000 bi-nucleated 
cells or 2000 mono-nucleated cells were counted per 
exposure dose per biological replicate (n ≥ 2), using the 
principles established by Fenech et  al. and in accord-
ance with the OECD Test No. 487: In Vitro Mammalian 
Cell Micronucleus Test guidelines [75, 76]. All con-
trols for the MN assay were within the acceptance cri-
teria based on historical ranges, with the average MN 
frequency for the positive control (Aflatoxin B1) lying 
between 2.2 and 2.8% and the negative, untreated con-
trol data between 0.8 and 1.4%. In all tests, the positive 
control had to be a minimum of two-fold greater than 
that of the untreated, negative control.
Data analysis and statistics
Statistical analysis was performed using Prism 8, 
GraphPad Software, Inc. (USA). Shapiro-Wilk test was 
used to calculate normality for each data set. For nor-
mally distributed data, One-way ANOVA with Sidak’s 
post hoc were used. For non-parametric data, Kruskal-
Wallis test was used to calculate significance when 
there were more than two variables, with Dunn’s multi-
ple comparisons test. For genotoxicity data sets, with ≥ 
2 biological replicates, a two-tailed Fischer’s Exact test 
was conducted.
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Additional file 1:  Figure S1: TEM micrographs of the ENM listed in 
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and (E) ZnO NM‑111. Image (A), (B), (C) and (D) reproduced from Keller 
et al. (2020) (https:// doi. org/ 10. 1080/ 17435 390. 2020. 18362 81) and image 
(E) reproduced from Yin et al. (2015) (https:// doi. org/ 10. 1007/ s11051‑ 
014‑ 2851‑y). Figure S2: A series of XRD patterns for the five ENMs listed 
in Table 1, (A)  TiO2 (NM‑105), (B) Ag (Sigma 576832), (C) ZnO (NM‑111), 
(D)  BaSO4 (NM‑220) and (E)  CeO2 (NM‑212). These graphs illustrate the 
crystalline phases for each material as summarised in Table 1. Figure S3: A 
series of XPS core level curves for the five ENMs included in this study and 
summarized in Table 1:  TiO2 (NM‑105), ZnO (NM‑111), Ag (Sigma 576832), 
 BaSO4 (NM‑220) and  CeO2 (NM‑212). Each curve is fitted by Lorentzian‑
Gaussian convoluted functions to determine the chemical composition. 
Figure S4: Representative images of micronuclei generated by automated 
scoring of HepG2 cells using a Metafer MetaSystem 3.9.8. (A) illustrates an 
enlarged image of a micronucleus shown in the scoring gallery pictured 
in (D), and highlighted with an orange outline. Representative images of 
micronuclei found within the HepG2 mononucleate (B, C) and binucleate 
(E–G) cell populations following prolonged and acute ENM exposures 
respectively.
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